Table 1 Transition probability matrix during a 1-year cycle
From: Is mass screening for coeliac disease a wise use of resources? A health economic evaluation
A-Symptom-free | B-Symptoms | C-Clinical evaluation | D-Compliant | E-Non-compliant | F-Death | |
|---|---|---|---|---|---|---|
A | 1–0.027–0.0090–0.0090–1.22*mra | 0.0027 | 0.0090 | 0.0090 | 0 | 1.22*mr |
B | 0 | 1–0.135b–0.450c–1.27*mr | 0.135b | 0.450c | 0 | 1.27*mr |
C | 0 | 0 | 1–0.522d–1.27*mr | 0.522d | 0 | 1.27*mr |
D | 0 | 0 | 0 | 0.86 (1–1.22*mr) | 0.14 (1–1.22*mr) | 1.22*mr |
E | 0 | 0 | 0 | 0.86 (1–1.27*mr) | 0.14 (1–1.27*mr) | 1.27*mr |
F | 0 | 0 | 0 | 0 | 0 | 1 |